Personal information

No personal information available

Activities

Collapse all

Works (7)

Data from Targeting the Synthetic Lethal Relationship between FOCAD and TUT7 Represents a Potential Therapeutic Opportunity for TUT4/7 Small-Molecule Inhibitors in Cancer

2024-12-03 | Preprint
DOI: 10.1158/1535-7163.c.7567753
Contributors: Robinson Triboulet; Khikmet Sadykov; Darren M. Harvey; David M. Wilson; Michael J. Steinbaugh; Christopher B. Mayo; Dillon Hawley; Andrew Madanjian; Corey Fyfe; Christina Bracken et al.
Source: check_circle
Crossref

Figure S1 from Targeting the Synthetic Lethal Relationship between FOCAD and TUT7 Represents a Potential Therapeutic Opportunity for TUT4/7 Small-Molecule Inhibitors in Cancer

2024-12-03 | Preprint
DOI: 10.1158/1535-7163.27951100
Contributors: Robinson Triboulet; Khikmet Sadykov; Darren M. Harvey; David M. Wilson; Michael J. Steinbaugh; Christopher B. Mayo; Dillon Hawley; Andrew Madanjian; Corey Fyfe; Christina Bracken et al.
Source: check_circle
Crossref

Figure S2 from Targeting the Synthetic Lethal Relationship between FOCAD and TUT7 Represents a Potential Therapeutic Opportunity for TUT4/7 Small-Molecule Inhibitors in Cancer

2024-12-03 | Preprint
DOI: 10.1158/1535-7163.27951097
Contributors: Robinson Triboulet; Khikmet Sadykov; Darren M. Harvey; David M. Wilson; Michael J. Steinbaugh; Christopher B. Mayo; Dillon Hawley; Andrew Madanjian; Corey Fyfe; Christina Bracken et al.
Source: check_circle
Crossref

Supplementary Data File 1 from Targeting the Synthetic Lethal Relationship between FOCAD and TUT7 Represents a Potential Therapeutic Opportunity for TUT4/7 Small-Molecule Inhibitors in Cancer

2024-12-03 | Preprint
DOI: 10.1158/1535-7163.27951094
Contributors: Robinson Triboulet; Khikmet Sadykov; Darren M. Harvey; David M. Wilson; Michael J. Steinbaugh; Christopher B. Mayo; Dillon Hawley; Andrew Madanjian; Corey Fyfe; Christina Bracken et al.
Source: check_circle
Crossref

Supplementary Materials and Methods from Targeting the Synthetic Lethal Relationship between FOCAD and TUT7 Represents a Potential Therapeutic Opportunity for TUT4/7 Small-Molecule Inhibitors in Cancer

2024-12-03 | Preprint
DOI: 10.1158/1535-7163.27951091
Contributors: Robinson Triboulet; Khikmet Sadykov; Darren M. Harvey; David M. Wilson; Michael J. Steinbaugh; Christopher B. Mayo; Dillon Hawley; Andrew Madanjian; Corey Fyfe; Christina Bracken et al.
Source: check_circle
Crossref

Supplementary Tables from Targeting the Synthetic Lethal Relationship between FOCAD and TUT7 Represents a Potential Therapeutic Opportunity for TUT4/7 Small-Molecule Inhibitors in Cancer

2024-12-03 | Preprint
DOI: 10.1158/1535-7163.27951088
Contributors: Robinson Triboulet; Khikmet Sadykov; Darren M. Harvey; David M. Wilson; Michael J. Steinbaugh; Christopher B. Mayo; Dillon Hawley; Andrew Madanjian; Corey Fyfe; Christina Bracken et al.
Source: check_circle
Crossref

Targeting the Synthetic Lethal Relationship between FOCAD and TUT7 Represents a Potential Therapeutic Opportunity for TUT4/7 Small-Molecule Inhibitors in Cancer

Molecular Cancer Therapeutics
2024-12-03 | Journal article
DOI: 10.1158/1535-7163.MCT-24-0176
Contributors: Robinson Triboulet; Khikmet Sadykov; Darren M. Harvey; David M. Wilson; Michael J. Steinbaugh; Christopher B. Mayo; Dillon Hawley; Andrew Madanjian; Corey Fyfe; Christina Bracken et al.
Source: check_circle
Crossref
How many people are using ORCID?